title: Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
abstract: A breast-fed female infant died suddenly in the neonatal period at 31 hours of age with profound macrovesicular fatty infiltration of liver, kidney, and muscle on postmortem examination, suggestive of a defect in fatty acid beta-oxidation. Fatty acid and palmitoyl-carnitine oxidation studies and direct enzyme study of cultured skin fibroblasts suggested a deficiency in the oxidation of long-chain fatty acids distal to carnitine palmitoyl-transferase I and before long-chain acyl-coenzyme A dehydrogenases. Deficient activity of carnitine-acylcarnitine translocase was demonstrated with intermediate levels of activity in the infant's parents, consistent with autosomal recessive inheritance. Fatty acid oxidation studies showed deficient oxidation of fatty acids at all chain lengths from C10:0 to C24:0, with partially reduced oxidation of C26:0 fatty acid, indicating the occurrence of a single mitochondrial carnitine-acylcarnitine translocase and demonstrating the requirement in vivo for L-carnitine for mitochondrial transport of all medium- and long-chain fatty acyl moieties. The disorder may have been precipitated in this breast-fed infant by poor initial feeding, fasting stress, and the long-chain triglycerides of human milk. The severity of the disorder prompted prenatal diagnosis, and affected siblings were excluded in two subsequent pregnancies by fatty acid oxidation in cultured chorionic villus cells and amniocytes.
authors.affiliation: Department of Child Health, St. George's Hospital Medical School, London, United Kingdom.
authors.forename: R A
authors.initials: RA
authors.lastname: Chalmers
authors.forename: C A
authors.initials: CA
authors.lastname: Stanley
authors.forename: N
authors.initials: N
authors.lastname: English
authors.forename: J S
authors.initials: JS
authors.lastname: Wigglesworth
mesh_terms: D000328:Adult; D000650:Amnion / Q000166:cytology / Q000201:enzymology; D001942:Breast Feeding; D002331:Carnitine / Q000627:therapeutic use; D002333:Carnitine Acyltransferases / Q000172:deficiency* / Q000235:genetics; D002334:Carnitine O-Palmitoyltransferase / Q000378:metabolism; D002823:Chorion / Q000166:cytology / Q000201:enzymology; D003937:Diagnosis, Differential; D005215:Fasting; D017809:Fatal Outcome; D044943:Fatty Acid Desaturases / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D005234:Fatty Liver / Q000175:diagnosis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005347:Fibroblasts / Q000201:enzymology; D005808:Genes, Recessive; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000175:diagnosis; D008052:Lipid Metabolism, Inborn Errors / Q000175:diagnosis* / Q000235:genetics; D008895:Milk, Human / Q000737:chemistry; D008928:Mitochondria / Q000201:enzymology*; D009135:Muscular Diseases / Q000175:diagnosis; D010084:Oxidation-Reduction; D010172:Palmitoylcarnitine / Q000378:metabolism; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012867:Skin / Q000201:enzymology / Q000473:pathology; D013312:Stress, Physiological / Q000378:metabolism / Q000503:physiopathology; D013398:Sudden Infant Death / Q000175:diagnosis*; D014280:Triglycerides / Q000032:analysis
chemical_list: D005227:Fatty Acids; D014280:Triglycerides; D010172:Palmitoylcarnitine; D044943:Fatty Acid Desaturases; D002333:Carnitine Acyltransferases; D002334:Carnitine O-Palmitoyltransferase; D002331:Carnitine